| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | 0.31 | 3e-08 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | 0.4 | 3e-08 |
| mRNA | BMS-536924 | GDSC1000 | pan-cancer | AAC | 0.2 | 3e-08 |
| mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | 0.18 | 5e-08 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | 0.25 | 9e-08 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.24 | 9e-08 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | 0.26 | 1e-07 |
| mRNA | VX-11e | GDSC1000 | pan-cancer | AAC | 0.19 | 2e-07 |
| mRNA | AS605240 | GDSC1000 | pan-cancer | AAC | 0.18 | 5e-07 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.25 | 6e-07 |